|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5324731A
(en)
|
1989-02-14 |
1994-06-28 |
Amira, Inc. |
Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
|
|
US5676978A
(en)
|
1989-02-14 |
1997-10-14 |
Amira, Inc. |
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
|
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
|
US5215882A
(en)
|
1989-11-30 |
1993-06-01 |
Ortho Diagnostic Systems, Inc. |
Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5837832A
(en)
|
1993-06-25 |
1998-11-17 |
Affymetrix, Inc. |
Arrays of nucleic acid probes on biological chips
|
|
US5807522A
(en)
|
1994-06-17 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for fabricating microarrays of biological samples
|
|
DE69621507T2
(de)
|
1995-03-28 |
2003-01-09 |
Japan Science And Technology Corp., Kawaguchi |
Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
|
|
US5843974A
(en)
*
|
1995-06-06 |
1998-12-01 |
Eli Lilly And Company |
Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
|
|
US5958342A
(en)
|
1996-05-17 |
1999-09-28 |
Incyte Pharmaceuticals, Inc. |
Jet droplet device
|
|
US6060240A
(en)
|
1996-12-13 |
2000-05-09 |
Arcaris, Inc. |
Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
|
|
US6090556A
(en)
|
1997-04-07 |
2000-07-18 |
Japan Science & Technology Corporation |
Method for quantitatively determining the expression of a gene
|
|
US5994076A
(en)
|
1997-05-21 |
1999-11-30 |
Clontech Laboratories, Inc. |
Methods of assaying differential expression
|
|
ES2276481T3
(es)
|
1997-12-12 |
2007-06-16 |
The University Of Western Ontario |
Peptido apoep1.b novedoso, composiciones y sus usos.
|
|
US6004755A
(en)
|
1998-04-07 |
1999-12-21 |
Incyte Pharmaceuticals, Inc. |
Quantitative microarray hybridizaton assays
|
|
US6048695A
(en)
|
1998-05-04 |
2000-04-11 |
Baylor College Of Medicine |
Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
|
|
US6087112A
(en)
|
1998-12-30 |
2000-07-11 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
|
US6316503B1
(en)
|
1999-03-15 |
2001-11-13 |
Tularik Inc. |
LXR modulators
|
|
US8257750B2
(en)
|
1999-04-30 |
2012-09-04 |
Kibow Biotech, Inc. |
Calcium carbonate compositions for preventing or treating hyperphosphatemia
|
|
AU2001280576A1
(en)
|
2000-07-18 |
2002-01-30 |
Uab Research Foundation |
Tissue-specific self-inactivating gene therapy vector
|
|
WO2002020737A2
(en)
|
2000-09-07 |
2002-03-14 |
Vanderbilt University |
Genome engineering by cell-permeable dna site-specific recombinases
|
|
DE60107449T2
(de)
|
2000-09-18 |
2005-12-08 |
Glaxo Group Ltd., Greenford |
Substituierte aminopropoxyarylderivate als lxr agonisten
|
|
AU2002219718A1
(en)
|
2000-12-13 |
2002-06-24 |
Sca Hygiene Products Zeist B.V. |
Process for oxidising primary alcohols
|
|
JP2003033179A
(ja)
|
2001-07-05 |
2003-02-04 |
Asahi Kasei Corp |
可逆的遺伝子導入ベクター
|
|
EP1497270A4
(en)
*
|
2002-03-27 |
2006-01-04 |
Smithkline Beecham Corp |
AMID COMPOUNDS AND METHOD FOR THEIR USE
|
|
AU2003226094A1
(en)
|
2002-03-27 |
2003-10-13 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
JP2005521721A
(ja)
|
2002-03-27 |
2005-07-21 |
スミスクライン・ビーチャム・コーポレイション |
酸およびエステル化合物ならびにその使用方法
|
|
EP1552010B1
(en)
|
2002-07-19 |
2010-06-09 |
Althea Technologies, Inc. |
Strategies for gene expression analysis
|
|
WO2004078939A2
(en)
|
2003-03-03 |
2004-09-16 |
University Of Massachusetts |
REGULATION OF Mdm2 FUNCTION
|
|
US7135575B2
(en)
*
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
US20050130919A1
(en)
|
2003-07-18 |
2005-06-16 |
University Of Massachusetts |
Regulatable promoters for synthesis of small hairpin RNA
|
|
AU2004283053A1
(en)
|
2003-10-20 |
2005-05-06 |
Nsgene A/S |
In vivo gene therapy of Parkinson's Disease
|
|
JP2007516258A
(ja)
|
2003-12-12 |
2007-06-21 |
ワイス |
心臓血管の疾患治療に有用なキノリン誘導体
|
|
FR2865736B1
(fr)
|
2004-02-02 |
2006-07-14 |
Synt Em |
Inhibiteurs de l'angiogenese, compositions les contenant et leur utilisation pour le traitement des maladies liees a une deregulation de l'angiogenese
|
|
WO2005112620A2
(en)
|
2004-05-18 |
2005-12-01 |
Massachusetts Institute Of Technology |
A cre-lox based method for conditional rna interference
|
|
JP5575357B2
(ja)
*
|
2004-07-02 |
2014-08-20 |
第一三共株式会社 |
組織因子産生抑制剤
|
|
DE602005017895D1
(de)
|
2004-07-07 |
2010-01-07 |
Merck & Co Inc |
Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
PL1802566T3
(pl)
|
2004-10-01 |
2009-05-29 |
Hoffmann La Roche |
Podstawione heksafluoroizopropanolem pochodne eteru
|
|
RU2382029C2
(ru)
|
2004-12-22 |
2010-02-20 |
Ф.Хоффманн-Ля Рош Аг |
Новые производные циклогексана
|
|
SE0500055D0
(sv)
|
2005-01-10 |
2005-01-10 |
Astrazeneca Ab |
Therapeutic agents 3
|
|
MX2007008370A
(es)
|
2005-01-10 |
2007-08-21 |
Astrazeneca Ab |
Derivados de 1,1-dioxidos de isotiazol-3 (2h) -ona como moduladores del receptor del higado x.
|
|
SE0500056D0
(sv)
|
2005-01-10 |
2005-01-10 |
Astrazeneca Ab |
Therapeutic agents 4
|
|
WO2006073364A1
(en)
|
2005-01-10 |
2006-07-13 |
Astrazeneca Ab |
Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
|
|
SE0500058D0
(sv)
|
2005-01-10 |
2005-01-10 |
Astrazeneca Ab |
Therapeutic agents 5
|
|
RU2007131400A
(ru)
|
2005-03-01 |
2009-04-10 |
Вайет (Us) |
Соединения циннолина и их применение в качестве модуляторов х-рецепторов печени
|
|
US8318760B2
(en)
|
2005-03-21 |
2012-11-27 |
Merck Sharp & Dohme Corp. |
Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use
|
|
KR101363278B1
(ko)
|
2005-06-27 |
2014-02-21 |
엑셀리시스 페이턴트 컴퍼니 엘엘씨 |
이미다졸계 ｌｘｒ 변조제
|
|
NZ567140A
(en)
|
2005-10-07 |
2011-09-30 |
Exelixis Inc |
Azetidines as MEK inhibitors for the treatment of proliferative diseases
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
US7790745B2
(en)
|
2005-10-21 |
2010-09-07 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline LXR Modulators
|
|
US20090062260A1
(en)
|
2005-11-14 |
2009-03-05 |
Irm Llc |
Compounds and compositions as lxr modulators
|
|
WO2007081335A1
(en)
|
2006-01-12 |
2007-07-19 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
US20100279918A1
(en)
|
2006-03-20 |
2010-11-04 |
Burnham Institute For Medical Research |
Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents
|
|
WO2008011071A2
(en)
*
|
2006-07-19 |
2008-01-24 |
The Regents Of The University Of California |
Interactions of hedgehog and liver x receptor signaling pathways
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
US8168666B2
(en)
|
2006-11-30 |
2012-05-01 |
Kowa Company, Ltd. |
Substituted carbinol compound
|
|
EP2121621B1
(en)
|
2006-12-08 |
2014-05-07 |
Exelixis Patent Company LLC |
Lxr and fxr modulators
|
|
JP2008179562A
(ja)
|
2007-01-24 |
2008-08-07 |
Kowa Co |
Ｌｘｒアゴニスト
|
|
US8993628B2
(en)
|
2007-02-23 |
2015-03-31 |
City Of Hope |
Synthetic ligands selective for LXRβ over LXRα, identification and methods of use thereof
|
|
US20100273816A1
(en)
|
2007-05-18 |
2010-10-28 |
Ronald Charles Bernotas |
Quinazoline Compounds
|
|
CA2691673A1
(en)
|
2007-06-29 |
2009-01-08 |
Avi Biopharma, Inc. |
Tissue specific peptide conjugates and methods
|
|
KR101171507B1
(ko)
|
2007-08-13 |
2012-08-07 |
에프. 호프만-라 로슈 아게 |
신규 피페라진 아마이드 유도체
|
|
TW200922582A
(en)
|
2007-08-20 |
2009-06-01 |
Organon Nv |
N-benzyl, N'-arylcarbonylpiperazine derivatives
|
|
US8039493B2
(en)
|
2007-09-27 |
2011-10-18 |
Hoffmann-La Roche Inc. |
Biaryl sulfonamide derivatives
|
|
DK2205737T3
(da)
*
|
2007-10-04 |
2013-05-21 |
Santaris Pharma As |
Mikromirer
|
|
WO2009060198A1
(en)
|
2007-11-09 |
2009-05-14 |
Peregrine Pharmaceuticals, Inc. |
Anti-vegf antibody compositions and methods
|
|
US8236753B2
(en)
*
|
2007-12-10 |
2012-08-07 |
The Brigham And Women's Hospital, Inc. |
RAP variants for drug delivery and methods of use thereof
|
|
EP2235020A1
(en)
|
2007-12-21 |
2010-10-06 |
Wyeth LLC |
Pyrazolo [1,5-a] pyrimidine compounds
|
|
CA2710458A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth Llc |
Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors
|
|
WO2009086123A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth |
Imidazo [1,2-a] pyridine compounds
|
|
AU2008345696A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth Llc |
Benzimidazole compounds
|
|
US7919509B2
(en)
|
2008-02-29 |
2011-04-05 |
Kowa Company, Ltd. |
2-oxochromene derivatives
|
|
AU2009255357A1
(en)
*
|
2008-05-29 |
2009-12-10 |
Bristol-Myers Squibb Company |
Methods for predicting patient response to modulation of the co-stimulatory pathway
|
|
CN102137680A
(zh)
*
|
2008-07-01 |
2011-07-27 |
克格诺西有限公司 |
用apoe肽治疗癌症的方法
|
|
WO2010036959A2
(en)
|
2008-09-26 |
2010-04-01 |
Dana-Farber Cancer Institute |
Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
|
|
US20120156216A1
(en)
*
|
2009-03-02 |
2012-06-21 |
Youngman Oh |
Methods and Compositions for Treatment of Tumor Metastasis
|
|
MY153958A
(en)
*
|
2009-05-28 |
2015-04-30 |
Exelixis Patent Co Llc |
Lxr modulators
|
|
WO2011115892A1
(en)
*
|
2010-03-15 |
2011-09-22 |
Griffin Patrick R |
Modulators of the retinoic acid receptor-related orphan receptors
|
|
US9421218B2
(en)
*
|
2010-04-13 |
2016-08-23 |
New York University |
Compositions and methods for treatment of melanoma
|
|
JP5851400B2
(ja)
|
2010-06-16 |
2016-02-03 |
Ｌｓｉｐファンド運営合同会社 |
大腸腫瘍の検出方法
|
|
EP2474617A1
(en)
*
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
|
US20130004481A1
(en)
*
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
|
TW201242953A
(en)
|
2011-03-25 |
2012-11-01 |
Bristol Myers Squibb Co |
Imidazole prodrug LXR modulators
|
|
WO2013043569A1
(en)
*
|
2011-09-20 |
2013-03-28 |
Vical Incorporated |
Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
|
|
WO2014028461A2
(en)
*
|
2012-08-13 |
2014-02-20 |
The Rockefeller University |
Treatment and diagnosis of melanoma
|